You have not yet registered? Get your account for free.
Forgot Password? We will send you a reset link
28 March 2024
Annual financial statements 2023
10 August 2023
Half-yearly financial statements 2023
30 March 2023
Annual financial statements 2022
10 November 2022
9M Präsentation (EN)
9M Results Presentation
11 August 2022
Half-yearly financial statements 2022
H122 Results Presentation
H122 Results Presentation (EN)
10 May 2022
3M22 Earnings Call
3M22 Unaudited Results
3M22 Unaudited Results (EN)
30 March 2022
Jahresabschluss 2021
Einzelabschluss 2021
Einzelabschluss 2021 (german only)
Entsprechenserklärung 2021
Declaration of Compliance 2021 (German only)
Annual financial statements 2021
3 March 2022
FY21 Preliminary Results (EN)
FY21 Preliminary Results
18 November 2021
11 August 2021
Half-yearly financial statements 2021
H1 Results Presentation
H1 Präsentation (EN)
5 April 2024
APONTIS PHARMA enters five-year distribution and marketing agreement with Novartis for two asthma medications and raises forecast
APONTIS PHARMA AG raises forecast after entering five-year distribution and marketing agreement with Novartis for two asthma medications
APONTIS PHARMA expects profitable growth again in 2024
6 February 2024
APONTIS PHARMA successfully completes performance and efficiency improvement program
9 November 2023
APONTIS PHARMA presents details of the restructuring and efficiency program – Nine-month figures for 2023 and new sales and earnings forecast for 2023 published
8 November 2023
APONTIS PHARMA AG with new forecast 2023 and details on announced restructuring program
08
May 24
Conference Call
Publication quarterly statement (call-date Q1)
13
Analysts’ Conference
17
Annual General Meeting
09
Aug 24
Publication half-yearly financial statements
